Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CERAMEDIX HOLDING, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-07-01 to 2024-06-30
Current total value of award: $1429485
Description: DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE